{"disease":{"id":"skin-kaposi-sarcoma","name":"skin kaposi sarcoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04577755","title":"Pomalidomide Treatment in Patients With Kaposi Sarcoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":45,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03077451","title":"Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT03601806","title":"Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT02799485","title":"sEphB4-HSA in Treating Patients With Kaposi Sarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}